[go: up one dir, main page]

FI970205L - Kaksoishybridijärjestelmä - Google Patents

Kaksoishybridijärjestelmä Download PDF

Info

Publication number
FI970205L
FI970205L FI970205A FI970205A FI970205L FI 970205 L FI970205 L FI 970205L FI 970205 A FI970205 A FI 970205A FI 970205 A FI970205 A FI 970205A FI 970205 L FI970205 L FI 970205L
Authority
FI
Finland
Prior art keywords
hybrid system
dual hybrid
dual
hybrid
Prior art date
Application number
FI970205A
Other languages
English (en)
Swedish (sv)
Other versions
FI970205A0 (fi
FI970205A7 (fi
Inventor
Bhabatosh Chaudhuri
Christine Stephan
Peter Fuerst
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI970205A0 publication Critical patent/FI970205A0/fi
Publication of FI970205L publication Critical patent/FI970205L/fi
Publication of FI970205A7 publication Critical patent/FI970205A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1055Protein x Protein interaction, e.g. two hybrid selection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Bioinformatics & Computational Biology (AREA)
FI970205A 1994-07-22 1995-07-12 Kaksoishybridijärjestelmä FI970205A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94810435 1994-07-22
PCT/EP1995/002724 WO1996003501A1 (en) 1994-07-22 1995-07-12 Dual hybrid system

Publications (3)

Publication Number Publication Date
FI970205A0 FI970205A0 (fi) 1997-01-17
FI970205L true FI970205L (fi) 1997-03-19
FI970205A7 FI970205A7 (fi) 1997-03-19

Family

ID=8218290

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970205A FI970205A7 (fi) 1994-07-22 1995-07-12 Kaksoishybridijärjestelmä

Country Status (6)

Country Link
EP (1) EP0775206A1 (fi)
JP (1) JPH11506301A (fi)
AU (1) AU2983295A (fi)
FI (1) FI970205A7 (fi)
NO (1) NO970258L (fi)
WO (1) WO1996003501A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69636866D1 (en) * 1995-04-11 2007-03-15 Gen Hospital Corp Reverse "two-hybrid"-systeme
WO1997031113A1 (en) * 1996-02-23 1997-08-28 Ariad Pharmaceuticals, Inc. Cell-based assay
CA2236867A1 (en) * 1996-09-27 1998-04-02 Icos Corporation Method to identify compounds for disrupting protein/protein interactions
US6093565A (en) * 1996-12-12 2000-07-25 Incyte Pharmaceuticals, Inc. Protein phosphatase regulatory subunit
WO1998046796A1 (en) * 1997-04-11 1998-10-22 The Regents Of The University Of California A method of screening nucleotide sequences to identify disruptors or effectors of biological processes or pathways
ATE342031T1 (de) 2001-07-26 2006-11-15 Procter & Gamble Absorbierende artikel mit elastischen oberen schichten
DE60230633D1 (de) 2002-11-08 2009-02-12 Procter & Gamble Absorbierender Wegwerfartikel mit schmutzverdeckender Deckschicht
EP1417947B1 (en) 2002-11-08 2006-03-08 The Procter & Gamble Company Disposable absorbent articles with improved topsheet
ATE473718T1 (de) 2003-10-02 2010-07-15 Procter & Gamble Absorbierender artikel mit elastomerischem material
EP1787609A1 (en) 2005-10-18 2007-05-23 The Procter and Gamble Company Absorbent Articles with Comfortable Elasticated Laminates
EP1776939A1 (en) 2005-10-18 2007-04-25 The Procter and Gamble Company Absorbent Articles with comfortable Elasticated Laminates
EP1803427B1 (en) 2005-12-28 2011-01-12 The Procter and Gamble Company Absorbent Articles with Comfortable Elasticated Laminates
EP1958604A1 (en) 2007-02-13 2008-08-20 The Procter & Gamble Company Disposable absorbent articles with separate part

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283173A (en) * 1990-01-24 1994-02-01 The Research Foundation Of State University Of New York System to detect protein-protein interactions
US5801144A (en) * 1992-01-28 1998-09-01 Karpas; Abraham Use of a compound for the manufacture of a medicament for the treatment of HIV infection
ATE242806T1 (de) * 1992-10-16 2003-06-15 Cold Spring Harbor Lab Umlagerung des cyclin komlexes und seine darauf bezogenen anwendungen
DE69333366T2 (de) * 1992-10-30 2004-09-16 The General Hospital Corp., Boston Ein neues zellzyklus kontrollprotein

Also Published As

Publication number Publication date
EP0775206A1 (en) 1997-05-28
WO1996003501A1 (en) 1996-02-08
JPH11506301A (ja) 1999-06-08
NO970258L (no) 1997-03-03
AU2983295A (en) 1996-02-22
NO970258D0 (no) 1997-01-21
FI970205A0 (fi) 1997-01-17
FI970205A7 (fi) 1997-03-19

Similar Documents

Publication Publication Date Title
DE69516129D1 (de) Hybridfahrzeug
FI964674A7 (fi) Rakennejärjestelmä
DE69621033D1 (de) Hybrid-flugzeug
DE69525187D1 (de) Reiseführersystem
DE19581765T1 (de) Wagen-Verwaltungssystem
FI941096A7 (fi) Autokohtainen telepysäköintijärjestelmä
DE59703193D1 (de) Koordinations-system
DE69729472D1 (de) Phonopneumograph system
DE69608485D1 (de) Hybridfahrzeug
DE69622210D1 (de) Hybridfahrzeug
ID17405A (id) Sistim elektrokromik
FI971557A7 (fi) Latausjärjestelmä
DE69507367D1 (de) Hybridschalter
NO971007L (no) Vakuumsystem
DE69526961D1 (de) Fahrzeug
DE59707793D1 (de) Umrichtersystem
FI944245L (fi) Radiopuhelinjärjestelmä
FI970205L (fi) Kaksoishybridijärjestelmä
DE69509571D1 (de) Hohlraumangepasster Hybridkoppler
NO985866L (no) Fortoejnings-system
DE69739136D1 (de) Hybrid-Modul
FI952737L (fi) Radiopuhelinjärjestelmä
DE69703718D1 (de) Hybrider Multiplexer
FI953885A0 (fi) Käyttökoneisto
DE69411598D1 (de) Betankungsanlage

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

FD Application lapsed